| Typicality: | 0.351 |
| Saliency: | 0.236 |
| for clinical trials | 2 | purpose |
| either as priming | 2 | manner |
| vaccine → be in → the pipeline | 13 |
| vaccine → come down → the pipeline | 4 |
| negative | neutral | positive |
| 0.193 | 0.548 | 0.259 |
| Raw frequency | 17 |
| Normalized frequency | 0.236 |
| Modifier score | 0.500 |
| Perplexity | 32.034 |